Novo Nordisk (spons. ADRs) Aktie

37,30 EUR -3,95 EUR -9,58 %

14:00:14

FSE

42,82 USD -4,78 USD -10,04 %

vorbörslich14:02:15

BTT

Novo Nordisk (spons. ADRs) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

KGV26,16Div. Rendite1,37%

WKN866931

ISINUS6701002056

SymbolNVO

Novo Nordisk (spons. ADRs) Aktien News

Sortieren:Datum Meistgelesen

06.03.25ZacksNovo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%

05.03.25MotleyFoolWhy Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It

05.03.25FOX BusinessNovo Nordisk cuts Wegovy prices in half for cash-paying consumers

05.03.25BenzingaNovo Nordisk Boosts Wegovy Access With Lower Pricing and Home Delivery

05.03.25ZacksNovo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

05.03.25PR NewswireNovo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients

05.03.25MotleyFoolDown 39%. Is Novo Nordisk Stock a Buy on the Dip?

05.03.25ZacksThe Zacks Analyst Blog Novo Nordisk, The Coca-Cola, Wells Fargo and Star Group

04.03.25ZacksTop Research Reports for Novo Nordisk, Coca-Cola & Wells Fargo

04.03.25Benzinga$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

04.03.25PR NewswireLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S(NVO) Shareholders

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO

03.03.25ZacksWall Street Analysts See Novo Nordisk (NVO) as a Buy: Should You Invest?

03.03.25ZacksIs Trending Stock Novo Nordisk A/S (NVO) a Buy Now?

27.02.25MotleyFoolPrediction: Novo Nordisk Will Soar Over the Next 5 Years. Here's 1 Reason Why.

27.02.25PR NewswireNovo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVO

24.02.25MotleyFoolWall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

21.02.25MotleyFoolWhy Novo Nordisk Stock Popped on Friday

21.02.25PR NewswireInvestors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO

20.02.25ZacksNovo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

19.02.25BenzingaSpotlight on Novo Nordisk: Analyzing the Surge in Options Activity

19.02.25Benzinga$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

19.02.25BenzingaNovo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages

19.02.25Business TimesAll assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account

19.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO

18.02.25PR NewswireLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Lawsuit - NVO

17.02.25PR NewswireNVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

14.02.25MotleyFoolNovo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon

13.02.25MotleyFoolWhy Novo Nordisk Stock Keeps Going Down

11.02.25MotleyFoolWhy Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

10.02.25ZacksIs It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?

08.02.25MotleyFoolIs Novo Nordisk Stock a Buy Now?

07.02.25PR NewswireNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

07.02.25BenzingaWhat the Options Market Tells Us About Novo Nordisk

07.02.25BenzingaNovo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data

06.02.25BenzingaNovo Nordisk Opposes 'Government Price Setting' As Elon Musk's DOGE Gains Access To CMS Amid Bernie Sanders' Criticism

05.02.25MotleyFoolWhy Novo Nordisk Stock Is Soaring Today

05.02.25New York TimesNovo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

05.02.25MotleyFoolNovo Nordisk (NVO) Q4 2024 Earnings Call Transcript

05.02.25BenzingaNovo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026

Novo Nordisk (spons. ADRs) News

Novo Nordisk (spons. ADRs) News: auf dieser Seite finden Sie alle Novo Nordisk (spons. ADRs) News und Nachrichten zur Novo Nordisk (spons. ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk (spons. ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk (spons. ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.